Literature DB >> 28265131

Medical Treatment for Postthrombotic Syndrome.

Federico Silva Palacios1, Suman Wasan Rathbun1.   

Abstract

Deep vein thrombosis (DVT) is a prevalent disease. About 20 to 30% of patients with DVT will develop postthrombotic syndrome (PTS) within months after the initial diagnosis of DVT. There is no gold standard for diagnosis of PTS, but clinical signs include pitting edema, hyperpigmentation, phlebectatic crown, venous eczema, and varicose veins. Several scoring systems have been developed for diagnostic evaluation. Conservative treatment includes compression therapy, medications, lifestyle modification, and exercise. Compression therapy, the mainstay and most proven noninvasive therapy for patients with PTS, can be prescribed as compression stockings, bandaging, adjustable compression wrap devices, and intermittent pneumatic compression. Medications may be used to both prevent and treat PTS and include anticoagulation, anti-inflammatories, vasoactive drugs, antibiotics, and diuretics. Exercise, weight loss, smoking cessation, and leg elevation are also recommended. Areas of further research include the duration, compliance, and strength of compression stockings in the prevention of PTS after DVT; the use of intermittent compression devices; the optimal medical anticoagulant regimen after endovascular therapy; and the role of newer anticoagulants as anti-inflammatory agents.

Entities:  

Keywords:  chronic venous insufficiency; deep vein thrombosis; postthrombotic syndrome

Year:  2017        PMID: 28265131      PMCID: PMC5334486          DOI: 10.1055/s-0036-1597765

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  45 in total

1.  Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?

Authors:  T Baglin
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 2.  Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.

Authors:  Jacqueline M Cohen; Elie A Akl; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Which pressure do we need to compress the great saphenous vein on the thigh?

Authors:  Bernhard Partsch; Hugo Partsch
Journal:  Dermatol Surg       Date:  2008-12       Impact factor: 3.398

5.  Evaluating optimal superficial limb perfusion at different angles using non-invasive micro-lightguide spectrophotometry.

Authors:  Geraldine Darmanin; Matthew Jaggard; Shehan Hettiaratchy; Jagdeep Nanchahal; Abhilash Jain
Journal:  J Plast Reconstr Aesthet Surg       Date:  2013-03-15       Impact factor: 2.740

Review 6.  Sample procurement for cultures of infected wounds: a systematic review.

Authors:  L R Copeland-Halperin; A J Kaminsky; N Bluefeld; R Miraliakbari
Journal:  J Wound Care       Date:  2016-04       Impact factor: 2.072

7.  Calf compression pressure required to achieve venous closure from supine to standing positions.

Authors:  Bernhard Partsch; Hugo Partsch
Journal:  J Vasc Surg       Date:  2005-10       Impact factor: 4.268

Review 8.  Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.

Authors:  Russell D Hull; Jane Liang; Grace Townshend
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 10.  Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.

Authors:  D N Kolbach; M W C Sandbrink; H A M Neumann; M H Prins
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.